Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome (2015)
- Authors:
- Guelsin, Gláucia A. S. - Universidade Estadual de Campinas (UNICAMP)
- Rodrigues, Camila
- Visentainer, Jeane E. L.
- Campos, Paula de Melo - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabíola
- Gilli, Simone C. O. - Universidade Estadual de Campinas (UNICAMP)
- Saad, Sara T. O. - Universidade Estadual de Campinas (UNICAMP)
- Castilho, Lilian - Universidade Estadual de Campinas (UNICAMP)
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.2450/2014.0332-13
- Subjects: HEMATOLOGIA; HEMATOPOESE; ANTÍGENOS; MEDULA ÓSSEA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Blood Transfusion
- ISSN: 1723-2007
- Volume/Número/Paginação/Ano: v. 13, p. 53-58, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
GUELSIN, Gláucia A. S. et al. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome. Blood Transfusion, v. 13, p. 53-58, 2015Tradução . . Disponível em: https://doi.org/10.2450/2014.0332-13. Acesso em: 29 maio 2024. -
APA
Guelsin, G. A. S., Rodrigues, C., Visentainer, J. E. L., Campos, P. de M., Traina, F., Gilli, S. C. O., et al. (2015). Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome. Blood Transfusion, 13, 53-58. doi:10.2450/2014.0332-13 -
NLM
Guelsin GAS, Rodrigues C, Visentainer JEL, Campos P de M, Traina F, Gilli SCO, Saad STO, Castilho L. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome [Internet]. Blood Transfusion. 2015 ; 13 53-58.[citado 2024 maio 29 ] Available from: https://doi.org/10.2450/2014.0332-13 -
Vancouver
Guelsin GAS, Rodrigues C, Visentainer JEL, Campos P de M, Traina F, Gilli SCO, Saad STO, Castilho L. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome [Internet]. Blood Transfusion. 2015 ; 13 53-58.[citado 2024 maio 29 ] Available from: https://doi.org/10.2450/2014.0332-13 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
Informações sobre o DOI: 10.2450/2014.0332-13 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
